Dr. Edginton has been featured in the Fall 2019 University of À¶Ý®ÊÓƵ Magazine.Ìý To see the article about her current research, click here.Ìý
Dr. Edginton has been invited as a tutor and presenter for the workshop; The Introduction on population and PBPK Modeling Pmetrics and PK-Sim in the beautiful Beverly Hills, California.Ìý
March 25 - 27, 2020.
The manuscript for "Open Systems Pharmacology community - an open access, open source, open science approach to modeling and simulation in pharmaceutical sciences" was accepted for publication in CPT: Pharmacometrics & Systems Pharmacology on September 23, 2019. Â
The Grand Challenges 2018 Annual Meeting (Oct 15-18, 2018) featured a panel on PBPK modeling and simulation in advancing drug development in global health. Dr. Edginton was invited by the Bill & Melinda Gates Foundation to participate along with:
Congratulations to Paul Malik for receiving a three year CIHR Doctoral Scholarship ($105,000 over three years). The tenure of the award is 2018-2021.
Andrea Edginton PhD, Michael Neely, MD (University of Southern California) and Joerg Lippert PhD (Bayer, Germany) receive a US FDA grant ($900,000 US 2018-2021) on PBPK and Population Modeling Seamlessly Linked to Clinical Trial Simulation in an Open-Source Software Platform.
Dr. Andrea Edginton, Dr. Shinya Ito (SickKids, Toronto) and Dr. Julie Autmizguine (St. Justine Hospital, Montreal) received a 4-year $680,000 CIHR Project grant awarded in Spring 2018. The project abstract is as follows:
"Predicting escitalopram exposure to breastfeeding infants: integrating analytical and in silico techniques", has been accepted for publication in Clinical Pharmacokinetics.
This manuscript presents a workflow for integrating breastmilk concentrations, feeding schedules and infant exposure through physiologically-based pharmacokinetic modelling for the purpose of hazard assessment. The work is the collaboration of SickKids in Toronto and The Pharmacokinetics Research Group (Edginton) at University of À¶Ý®ÊÓƵ.Ìý
Dr. Alfonso Iorio (McMaster) (NPA), Dr. Andrea Edginton (PA), Dr. Man Chiu Poon (U Calgary) (PA) received a 3-yr project grant (Fall 2017 competition) entitled:
Personalized Medicine for Canadians with Hemophilia: a pragmatic evaluation of Web-Accessible Population Pharmacokinetics Service-Hemophilia (WAPPS-hemo) tailored dosing
This research will evaluate the effectiveness, safety and economics of the WAPPS-Hemo platform (www.wapps-hemo.org) in personalizing hemophilia treatment through pharmacokinetic modeling at 5 Canadian hemophilia centres.Ìý
Dr. Edginton has been invited to the Bill & Melinda Gates Medical Research Institute event -- 2018 PD Challenge Workshop: Collaborating to Improve Translational Medicine in Global Health being held April 26-27, 2018 at the Boston Marriott Copley Place.